Acute Asthma Exacerbation in Children: Assessment and Management
Written by Dr. Muhammad Salar Raza · Manually reviewed by Dr. Muhammad Salar Raza · Content updated
Clinical Pathway
Grade severity by work of breathing, oxygen saturation, ability to speak, and peak flow where obtainable. Give oxygen to maintain saturation above 94% and inhaled salbutamol by spacer or nebulizer, repeated every 20 minutes in the first hour for moderate to severe attacks. Add systemic corticosteroids early: oral prednisolone for most, intravenous if unable to tolerate or in critical attacks. Add nebulized ipratropium bromide for severe or poorly responding episodes, and consider intravenous magnesium sulfate when refractory. Admit for observation if response is incomplete, and involve intensive care for silent chest, exhaustion, or rising carbon dioxide. Review inhaler technique and trigger control before discharge with an action plan.
Clinical Reasoning
Beware the silent chest: disappearing wheeze with rising respiratory effort or exhaustion signals critical airflow limitation, not improvement. Speech in single words, saturation below 92% in air, and peak flow under half of predicted mark severe attacks. Steroids take 4-6 hours to act, which is exactly why they are given early rather than after bronchodilators fail. Antibiotics are not indicated unless there is clear evidence of bacterial infection, since most exacerbations are viral or allergen triggered. Chest X-ray is unnecessary in a straightforward exacerbation and is reserved for suspected pneumothorax, foreign body, or consolidation.
Sample MCQ
A 6-year-old boy with known asthma arrives with breathlessness, wheeze, oxygen saturation of 90% in air, and ability to speak only in words. What is the most appropriate first-line treatment combination?
- AOxygen, nebulized salbutamol, and oral prednisolone
- BOral montelukast alone
- CIntravenous ceftriaxone
- DChest physiotherapy and observation
Correct Answer: Oxygen, nebulized salbutamol, and oral prednisolone
Saturation of 90% with speech in words defines a severe exacerbation, treated with controlled oxygen, repeated inhaled short-acting beta-agonist, and early systemic corticosteroid; ipratropium can be added if response is poor. Montelukast is a controller medication and has no role as rescue therapy in an acute attack. Ceftriaxone treats bacterial infection, but acute asthma exacerbations are usually viral or allergen driven, and antibiotics are not routinely indicated. Chest physiotherapy does not relieve bronchospasm and observation alone leaves a hypoxemic child untreated, risking progression to respiratory failure.
Guidelines and further reading
Related Clinical Topics
Community-Acquired Pneumonia (CAP): Diagnosis and Management
Suspect CAP in patients with cough, fever, sputum, and focal chest signs, and confirm with a chest radiograph showing new infiltrate. Stratify severity with CURB-65 (confusion, urea, respiratory rate, blood pressure, age 65 or older). Low-risk patients are treated as outpatients with amoxicillin, adding or substituting a macrolide for atypical coverage where appropriate. Patients admitted to the ward receive a beta-lactam such as ceftriaxone plus a macrolide such as azithromycin, while severe CAP requiring ICU care needs broader coverage and exclusion of resistant pathogens. Give antibiotics within 4 hours, support oxygenation, and reassess at 48-72 hours.
COPD & Smoking Cessation Counseling: Ethical and Clinical Guidelines
When a patient consistently refuses recommended lifestyle changes such as smoking cessation, the most appropriate approach is to respect their autonomy while maintaining a supportive, non-judgmental stance. This ensures the therapeutic relationship is preserved and leaves the door open for future interventions when the patient is ready to reconsider. Physicians have a professional duty to provide care, and withdrawing care as a punitive measure for a patient's lifestyle choices is against medical ethics. Coercion or breaching confidentiality without explicit consent or imminent harm is highly unethical.
Pulmonary Embolism: Diagnosis and Management
Pulmonary embolism (PE) is a life-threatening condition caused by a blockage in one of the pulmonary arteries in the lungs, most commonly due to a blood clot that has traveled from a deep vein in the legs or pelvis (deep vein thrombosis). This obstruction impedes blood flow to parts of the lung, leading to impaired gas exchange and potential cardiovascular collapse. Acute treatment typically involves prompt anticoagulation with agents such as unfractionated heparin, low molecular weight heparin, or direct oral anticoagulants (DOACs) to prevent clot propagation and new clot formation. In high-risk PE with hemodynamic instability, thrombolysis (fibrinolysis) may be administered to dissolve the clot. Surgical pulmonary embolectomy or catheter-directed interventions are considered for patients with massive PE who cannot receive or have failed thrombolysis. Symptoms are often non-specific and can include sudden onset of dyspnea, pleuritic chest pain (pain on breathing), and cough. Signs may include tachypnea (rapid breathing), tachycardia (rapid heart rate), hypoxemia, and in severe cases, syncope, hypotension, or signs of right heart failure. Hemoptysis (coughing up blood) may also occur.
SMLE Preparation Resources
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks